UNICA IRIS Institutional Research Information System

FARCI, PATRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 66.773
NA - Nord America 5.550
AS - Asia 2.277
SA - Sud America 284
AF - Africa 45
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 74.940
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 62.448
US - Stati Uniti d'America 5.497
NL - Olanda 2.930
SG - Singapore 917
CN - Cina 881
UA - Ucraina 457
SE - Svezia 311
BR - Brasile 227
FI - Finlandia 165
VN - Vietnam 147
DE - Germania 139
GB - Regno Unito 139
FR - Francia 106
HK - Hong Kong 73
KR - Corea 56
IN - India 48
BD - Bangladesh 24
CA - Canada 24
IQ - Iraq 21
AR - Argentina 20
RU - Federazione Russa 18
JP - Giappone 14
IR - Iran 13
MX - Messico 13
EC - Ecuador 12
PK - Pakistan 12
ZA - Sudafrica 12
AT - Austria 10
ID - Indonesia 10
EG - Egitto 9
UZ - Uzbekistan 9
MA - Marocco 8
PH - Filippine 8
PL - Polonia 8
LT - Lituania 7
VE - Venezuela 7
CL - Cile 6
IE - Irlanda 6
KZ - Kazakistan 6
TH - Thailandia 6
TR - Turchia 6
CO - Colombia 5
EU - Europa 4
GR - Grecia 4
KE - Kenya 4
RO - Romania 4
AU - Australia 3
AZ - Azerbaigian 3
DK - Danimarca 3
ES - Italia 3
GE - Georgia 3
JM - Giamaica 3
MY - Malesia 3
PA - Panama 3
SA - Arabia Saudita 3
UY - Uruguay 3
BE - Belgio 2
CG - Congo 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
KG - Kirghizistan 2
MU - Mauritius 2
NI - Nicaragua 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PY - Paraguay 2
SV - El Salvador 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EE - Estonia 1
FJ - Figi 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
NR - Nauru 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
ZW - Zimbabwe 1
Totale 74.940
Salva come PNG Salva come JPEG
Città #
Cagliari 61.475
Amsterdam 2.924
Uta 761
Fairfield 586
Singapore 494
Chandler 481
Woodbridge 450
Ashburn 406
Houston 366
San Jose 295
Boardman 256
Ann Arbor 249
Jacksonville 243
Seattle 235
Wilmington 230
Dallas 212
Cambridge 200
Nyköping 180
Beijing 162
Dearborn 123
Hefei 99
Helsinki 88
Santa Clara 87
Los Angeles 78
Nanjing 71
Lauterbourg 70
Boston 69
Buffalo 63
Hong Kong 63
Seoul 56
Shanghai 48
The Dalles 45
Ho Chi Minh City 40
Milan 40
Guangzhou 33
San Diego 32
Hanoi 30
Shenyang 26
Hebei 22
Nanchang 22
New York 22
Changsha 20
Verona 20
Redwood City 18
São Paulo 18
Jiaxing 17
Sassari 17
Chicago 16
London 15
Munich 14
Pune 14
Falls Church 13
Frankfurt am Main 13
Orem 13
Tianjin 13
Norwalk 12
Tokyo 12
Zhengzhou 12
Manchester 11
Council Bluffs 10
Mountain View 10
Orange 10
Toronto 10
Auburn Hills 9
Guasila 9
Ningbo 9
Renton 9
Rio de Janeiro 9
Atlanta 8
Brooklyn 8
Da Nang 8
Dong Ket 8
Baghdad 7
Denver 7
Haiphong 7
Jinan 7
Redmond 7
Redondo Beach 7
Tashkent 7
Warsaw 7
Washington 7
Belo Horizonte 6
Brasília 6
Chennai 6
Dhaka 6
Kunming 6
Turku 6
Vienna 6
Cairo 5
Dublin 5
Mexico City 5
Phoenix 5
Porto Alegre 5
Rome 5
Bangkok 4
Chongqing 4
Columbus 4
Düsseldorf 4
Guayaquil 4
Jakarta 4
Totale 71.976
Salva come PNG Salva come JPEG
Nome #
Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively 2.998
Liver Regeneration Signature in Hepatitis B Virus (HBV)-Associated Acute Liver Failure Identified by Gene Expression Profiling 2.970
Neutralizing antibodies to hepatitis C virus in perinatally infected children followed up prospectively 2.762
Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis 2.690
Viral expression and molecular profiling in liver tissue versus microdissected hepatocytes in hepatitis B virus - associated hepatocellular carcinoma. 2.617
Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma 2.540
Association of chronic hepatitis C with recurrent brief depression 2.470
Integrated ordination of miRNA and mRNA expression profiles 2.353
Evaluation of antibodies to hepatitis C virus in a long-term prospective study of post-transfusion hepatitis among thalassemic children: comparison between first- and second- generation assay 2.245
Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue 2.206
Natural history of hepatitis C in thalassemia major: a long-term prospective study 2.152
Treatment of chronic hepatitis C in patients with glucose-6-phosphate dehydrogenase deficiency: is ribavirin harmful? 1.704
Epidemiology of infection with HIV-1 in Sardinia: a multicentre prospective study 1.700
Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure 1.697
Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma 1.688
Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B 1.640
null 1.610
Molecular signature and mechanisms of hepatitis D virus–associated hepatocellular carcinoma 1.514
Hepatic stem cells and transforming growth factor beta in hepatocellular carcinoma 1.463
null 1.445
Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: On-treatment kinetics of HBsAg serum levels vary by HBV genotype 1.442
Clinical Features of Hepatitis D 1.416
Specificity of an anti-capsid antibody associated with Hepatitis B Virus-related acute liver failure 1.371
New Insights into the HCV Quasispecies and Compartmentalization 1.356
Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a. 1.264
Experimental transmission of hepatitis C virus associated fulminant hepatitis to a chimpanzee 1.260
Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone. 1.155
Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. 1.116
The use of molecular assays in the management of viral hepatitis 867
Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a. 823
Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy 769
Viral escape and the failure of cellular immune responses 681
Treatment of chronic hepatitis D 644
Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C 591
Treatment of patients with Chronic Hepatitis Delta 576
Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin 556
Treatment of chronic hepatitis D: New advances, old challenges 545
Predicting response to peginterferon alfa-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B 543
Chronic viral hepatitis D 533
Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome 531
In Vivo study of the HC-TN Strain of Hepatitis C Virus Recovered from a Case of Fulminant Hepatitis: RNA Transcripts of a Molecular Clone (pHC-TN) are Infectious in Chimpanzees but not in Huh7.5 cells 513
The economics of treating chronic hepatitis C patients with peginterferon alpha-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase 501
Natural history and experimental models of hepatitis C 496
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies 496
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B 489
Hepatitis D (Delta) Virus 467
Implicazioni biologiche e cliniche della quasispecie virale 465
Immune Response to Hepatitis C Virus 465
Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection 458
The quasispecies of hepatitis C virus and host immune response 447
Clinical relevance of hepatitis C virus genetic variability 444
L’epatite delta 440
Lack of protective immunity against reinfection with hepatitis C virus 439
A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures 438
Hepatitis C virus associated fulminant hepatic failure 415
Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. 402
Long term study of hepatitis C virus replication in non-A non-B hepatitis 401
null 399
Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassemic children 362
Prevention of hepatitis C virus infection in chimpanzee by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein 358
Milestones in Liver Disease 354
Delta hepatitis: an update 354
Acute viral hepatitis in Saudi Arabia: seroepidemiological analysis, risk factors, clinical manifestations, and evidence for a sixth hepatitis agent. 351
Virological mechanisms of viral persistence, resolution and reinfection 350
The role of pre-core hepatitis B virus mutants on the long-term outcome of chronic hepatitis B virus hepatitis. A longitudinal study. 348
Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels. 346
Peginterferon alfa-2a (40 KD) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels 344
Hepatitis C virus. The importance of viral heterogeneity 343
Hepatitis type C after orthotopic liver transplantation: reinfection and disease recurrence. 329
Molecular basis of viral resistance to interferon in chronic hepatitis C 312
La ricerca biomedica 307
Prevention of hepatitis C virus infection in chimpanzee after antibody-mediated in vitro neutralization 305
HCV-associated lymphomas 303
Immunity elicited by hepatitis C virus. 295
HCV diversity, dynamics and turnover 293
Clinical significance of hepatitis C virus genotypes and quasispecies 284
Treatment of chronic hepatitis D with interferon alfa-2a 210
Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis 204
Totale 75.030
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.868
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.868
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.615 0 0 0 0 0 0 0 0 0 744 514 357
2021/20224.003 303 418 235 246 362 341 282 230 261 293 501 531
2022/20235.574 620 696 748 416 541 495 145 860 333 227 240 253
2023/20244.801 397 263 272 453 462 667 534 317 221 398 445 372
2024/20255.331 499 504 778 525 385 456 395 83 196 1.166 148 196
2025/20264.845 256 137 474 246 289 265 502 185 2.092 399 0 0
Totale 75.030